Maynard Um
-
-
-
-
-
-
-
Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 13c
-
-
-
-
-
-
-
Aquestive Therapeutics price target raised to $12 at Citizens on Anaphylm patents
-
-
-
-
-
-
-
Aquestive Therapeutics promotes Korczynski to chief commercial officer
-
-
-
-
-
-
-
Aquestive Therapeutics Inc. (AQST) Misses Q1 EPS by 8c
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Aquestive Therapeutics (AQST)
-
-
-
-
-
-
-
Aquestive Therapeutics (AQST) PT Raised to $13 at Leerink Partners
-
-
-
-
-
-
-
Aquestive Therapeutics (AQST) Reports Positive Topline Data for Anaphylm
-
455,693 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

